Overview:

The global ethiodized oil market is valued for more than US$ XXX.X Mn in 2019 and expected to reach a value of US$ XXX.X Mn by 2029 with a significant CAGR of around XX.X% over the forecast period of 2019-2029. The ethiodized oil is poppyseed oil which is used as a radio-opaque contrast agent for radiological investigation. It is mainly used for diagnosis of various type of cancer.

Market Dynamics:

Growing tumor cases across the globe is a major factor expected to drive the growth of global ethiodized oil market. The rising prevalence of tumor cases is expected to led demand of ethiodized oil for early detection drugs and procedures.

In addition, rising infertility among women across the globe is another key factor driving growth of the global market. The primary reason for infertility is ovulation problem and secondarily because of blocked fallopian tubes. According to US Department of Health And Human Services, 12 to 13 families out of 100 have trouble in becoming parents. The tests such as X-ray hysterosalpingogram and chromopertubation are used for determining blockages in fallopian tubes. Thus the demand for these tests is expected to fuel growth of the global market in the near future.

However, side effects and reactions such as exacerbation of chronic liver disease, pulmonary and cerebral embolism, thyroid dysfunction, etc. are associated with use of ethiodized oil which may hamper growth of the global ethiodized oil market to a certain extent.

Key Trends:

Rising focus on product launches and approvals by key players is a key trend supporting growth of the global ethiodized oil market. For instance, major producer of Ethiodized oil, Guerbet, has listed out countries that have indication of Lymphography and has got the drug approval in 47 countries. Moreover, in 2019, the company has taken drug approval in Switzerland and India, and in 2020, the drug received approval in Ireland.

Regional Analysis:

For detailed understanding of market dynamics, the global market is analyzed across key regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Europe region holds major share in the global market followed by North America. Significant growth in healthcare spending and growing demand for cancer treatment in countries in the region are some key factors supporting market growth in countries in the region. However, Asia Pacific is expected to witness highest growth during the forecast period.

Scope of the Report:

Detailed Segmentation:

Global Ethiodized Oil Market, By Application:

• Chemoembolization
• Lymphangiography
• Hysterosalpingography

Key Players Covered:

Key players operating in the market includes, Guerbet LLC, Simagchem Corporation, Chemwill Asia Co. Ltd., Wuhan Monad Medicine Tech Co. LTD, and Afine Chemicals Ltd.

Key features of the study:

Foresight Market Research provides detailed analysis on global market in our report- Global Ethiodized Oil Market by application and region. The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, and regional outlook. The report delivers competitive analysis about leading players in the global ethiodized oil market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, ongoing trends, market expansion, and marketing tactics used overall the globe.